Key Takeaways
- • Eka Ventures closed its second fund at £80 million, bringing total assets under management to approximately $200 million, positioning itself as the UK's largest early-stage impact venture capital investor focused on health, wellbeing, and sustainability sectors.
- • The sophomore fund close represents significant capital deployment in the impact investing space, demonstrating institutional appetite for venture investments aligned with environmental, social, and governance (ESG) criteria across early-stage companies.
- • Eka Ventures' fund strategy targets health, wellbeing, and sustainability verticals, sectors increasingly attracting institutional capital as limited partners prioritize impact-aligned returns alongside financial performance.
Summary
Eka Ventures has completed the closure of its second institutional venture capital fund at £80 million, according to announcement details. The fund close elevates the firm's total assets under management to approximately $200 million, establishing Eka Ventures as the UK's largest early-stage impact venture capital investor specializing in health, wellbeing, and sustainability technologies and businesses.
The sophomore fund represents a meaningful capital commitment to impact-oriented venture investing at the early stage, a market segment that has experienced sustained institutional demand from family offices, pension funds, and asset managers seeking investment exposure to companies addressing healthcare accessibility, wellbeing solutions, and environmental sustainability challenges. The fund's close timing and size reflect investor confidence in Eka Ventures' deployment model and thesis execution within the impact venture ecosystem.
The firm's focus on early-stage health, wellbeing, and sustainability investment aligns with broader institutional trends toward ESG-integrated investment strategies and impact measurement. By raising a larger sophomore fund relative to predecessor vehicles, Eka Ventures signals successful track record validation and demonstrates LP conviction in the firm's investment approach, sourcing capabilities, and portfolio company value creation methodology within these targeted sectors.
The sophomore fund represents a meaningful capital commitment to impact-oriented venture investing at the early stage, a market segment that has experienced sustained institutional demand from family offices, pension funds, and asset managers seeking investment exposure to companies addressing healthcare accessibility, wellbeing solutions, and environmental sustainability challenges. The fund's close timing and size reflect investor confidence in Eka Ventures' deployment model and thesis execution within the impact venture ecosystem.
The firm's focus on early-stage health, wellbeing, and sustainability investment aligns with broader institutional trends toward ESG-integrated investment strategies and impact measurement. By raising a larger sophomore fund relative to predecessor vehicles, Eka Ventures signals successful track record validation and demonstrates LP conviction in the firm's investment approach, sourcing capabilities, and portfolio company value creation methodology within these targeted sectors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.